ClearPoint Neuro (CLPT) Accumulated Expenses (2018 - 2025)
Historic Accumulated Expenses for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $3.5 million.
- ClearPoint Neuro's Accumulated Expenses fell 327.37% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 327.37%. This contributed to the annual value of $4.9 million for FY2024, which is 6576.18% up from last year.
- As of Q3 2025, ClearPoint Neuro's Accumulated Expenses stood at $3.5 million, which was down 327.37% from $2.9 million recorded in Q2 2025.
- ClearPoint Neuro's 5-year Accumulated Expenses high stood at $4.9 million for Q4 2024, and its period low was $990000.0 during Q1 2021.
- Over the past 5 years, ClearPoint Neuro's median Accumulated Expenses value was $2.3 million (recorded in 2023), while the average stood at $2.4 million.
- As far as peak fluctuations go, ClearPoint Neuro's Accumulated Expenses soared by 6576.18% in 2024, and later tumbled by 327.37% in 2025.
- ClearPoint Neuro's Accumulated Expenses (Quarter) stood at $2.6 million in 2021, then increased by 8.45% to $2.8 million in 2022, then increased by 4.36% to $2.9 million in 2023, then soared by 65.76% to $4.9 million in 2024, then fell by 28.02% to $3.5 million in 2025.
- Its Accumulated Expenses was $3.5 million in Q3 2025, compared to $2.9 million in Q2 2025 and $1.9 million in Q1 2025.